9068 Results

Congress Abstract

Salivary gland Radiotherapy for Sialorrhea Treatment in Amyotrophic Lateral Sclerosis patients.

Authors:

Avi ASSOULINE1, Antoine Schernberg2, Maria del Mar Amador3, Capucine Morelot-Panzini4, Jesus Gonzalez-Bermejo5, Timothée Lenglet3, Nadine Le Forestier3, Gaelle Bruneteau3, François Salachas3, Sylvie Delanian1, Pierre-François Pradat3

1Centre de Cancérologie de la Porte de Saint Cloud, Radiation Oncology, Boulogne Billancourt, France; 2Centre de Cancérologie de la Porte de Saint Cloud, Radiation Oncology, Paris, France; 3Paris ALS center, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris (APHP), Departement of Nervous System Diseases, Paris, France; 4Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris (APHP), Departement of Pneumology , Paris, France; 5Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris (APHP), Departement of Pneumology and Intensive Care, Paris, France

Show Affiliations

Congress Abstract

Hypofractionated radiotherapy for breast cancer: Findings from an international ESTRO-GIRO survey

Authors:

Melinda Mushonga1,2, Jessica Weiss 3, Amy Zhihui Liu4,5, Osama Mohamad 6, Yolande Lievens 7, Danielle Rodin1, Danielle Rodin8

1Princess Margaret Cancer Center, Radiation Oncology, Toronto, Canada; 2Sally Mugabe Hospital, Department of Oncology, Harare, Zimbabwe; 3 Princess Margaret Cancer Centre, Department of Biostatistics, Toronto, Canada; 4Princess Margaret Cancer Centre, Department of Biostatistics, Toronto, Canada; 5Dalla Lana School of Public Health, University of Toronto, Biostatistics, Toronto, Canada; 6 University of California , , Department of Radiation Oncology, San Francisco, USA; 7Ghent University Hospital and Ghent University, Department of Radiation Oncology, Ghent, Belgium; 8University of Toronto, Radiation Oncology Program, Toronto, Canada

Show Affiliations

Congress Abstract

This house believes: Combination therapy for intermediate and high-risk pCa represents the best standard of care

Authors:

Mira Keyes1

1BC Cancer, Radiation Oncology, Vancouver, Canada

Show Affiliations

Congress Abstract

Influence of heterogeneities on the dose calculation accuracy in proton beam therapy

Authors: Ruangchan|, Sirinya(1,2)*[n01613720@students.meduniwien.ac.at];Knäusl |, Barbara(1,3);Fuchs|, Hermann(1,3);Georg|, Dietmar(1);Clausen|, Monika(1);
(1)Medical University of Vienna, Department of Radiation Oncology, Vienna, Austria;(2)King Chulalongkorn Memorial Hospital, Department of Radiology, Bangkok, Thailand;(3)EBG MedAustron GmbH, Medical Department, Wiener Neustadt, Austria;
Show Affiliations

Congress Abstract

Effects of atelectasis changes on geometric and dosimetric in tumor and lung tissue for lung cancer

Authors:

Hua Chen1, Zhiyong Xu2

1shanghai chest hospital, Radiation Oncology, Shanghai, China; 2Shanghai chest hospital, Radiation Oncology, Shanghai, China

Show Affiliations

Journal Article

Contact of a tumour with the pleura is not associated with regional recurrence following stereotactic ablative radiotherapy for early stage non-small cell lung cancer

Authors: Krista C.J. Wink, Steffen Löck, Maddalena Rossi, Angela van Baardwijk, José Belderbos, Dirk de Ruysscher, Esther G.C. Troost

Congress Abstract

Lung SABRT treatment in oligometastatic patients, a prospective review

Authors: Csiki|, Emese(1)*[emesecsiki@yahoo.com];Simon|, Mihály(1,2);Papp|, Judit(1,2);Kovács|, Árpád(1,2);
(1)University of Debrecen, Clinic of Oncoradiology, Debrecen, Hungary;(2)University of Pécs, Faculty of Health Sciences- Doctoral School of Health Sciences, Pécs, Hungary;
Show Affiliations

Journal Article

The tubarial salivary glands: A potential new organ at risk for radiotherapy

Authors: Matthijs H. Valstar, Bernadette S. de Bakker, Roel J.H.M. Steenbakkers, Kees H. de Jong, Laura A. Smit, Thomas J.W. Klein Nulent, Robert J.J. van Es, Ingrid Hofland, Bart de Keizer, Bas Jasperse, Alfons J.M. Balm, Arjen van der Schaaf, Johannes A. Langendijk, Ludi E. Smeele, Wouter V. Vogel

Congress Abstract

Circadian rhythm effects on radiotherapy toxicity

Authors:

Christopher Talbot1, Adam Webb1, Emily Harper1, David Azria2, Ananya Choudhury3, Dirk De Ruysscher4, Alison Dunning5, Rebecca Elliott3, Sarah Kerns6, Maarten Lambrecht7, Tiziana Rancati8, Barry Rosenstein9, Petra Seibold10, Elena Sperk11, Ana Vega12, Liv Veldeman13, Jenny Chang-Claude14, Catharine West3, Tim Rattay15, R. Paul Symonds16

1University of Leicester, Genetics, Leicester, United Kingdom; 2Montpellier Cancer Institute, Department of Radiation Oncology, Montpellier, France; 3University of Manchester, Division of Cancer Sciences, Manchester, United Kingdom; 4Maastricht University Medical Center, Department of Radiation Oncology (Maastro clinic), Maastricht, The Netherlands; 5University of Cambridge, Centre for Cancer Genetic Epidemiology, Cambridge, United Kingdom; 6University of Rochester, Department of Radiation Oncology , Rochester, NY, USA; 7UZ Leuven, Radiation Oncology, Leuven, Belgium; 8Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate Cancer Program, Milano, Italy; 9Icahn School of Medicine at Mount Sinai, Department of Radiation Oncology, New York, USA; 10German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany; 11Medical Faculty Mannheim, Department of Radiation Oncology, Mannheim, Germany; 12Fundación Pública Galega Medicina Xenómica, Instituto de Investigación Sanitaria, Santiago de Compostela, Spain; 13Ghent University Hospital, Department of Radiation Oncology, Ghent, Belgium; 14University Medical Center Hamburg-Eppendorf, University Cancer Center , Hamburg, Germany; 15University of Leicester, Leicester Cancer Research Centre, Leicester, United Kingdom; 16University of Leicester, Leicester Canceer Research Cenre, Leicester, United Kingdom

Show Affiliations

Congress Abstract

Standardization influences repeatability and prognostic value of radiomic features

Authors: Fornacon-wood|, Isabella(1)*[isabella.fornacon-wood@postgrad.manchester.ac.uk];O'Connor|, James(1);Faivre-Finn|, Corinne (1);Price|, Gareth(1);
(1)The University of Manchester, Division of Cancer Sciences, Manchester, United Kingdom;
Show Affiliations
*:*